Drábek Jiří Ph.D.
Journals
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients.
Translational Lung Cancer Research.
2023,
12(5),
1034-1050,
ISSN: 2226-4477 ,
PMID: 37323172,
Development and extensive analytical validation of deep amplicon sequencing for detecting KRAS and NRAS mutations in metastatic colorectal cancer samples.
Neoplasma.
2021,
69(1),
203-2015,
ISSN: 0028-2685,
PMID: 34881628,
Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study.
Scientific Data.
2021,
8(1),
296,
ISSN: 2052-4463,
PMID: 34753956,
Books & book chapters
Genetic risk calculation of cystic fibrosis in prenatal testing,
1.vyd.,
Olomouc,
Palacky University,
2021,
45,
357-366,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
Laboratory Techniques in Cellular and Molecular Medicine,
1.vyd.,
Olomouc,
Palacky University,
2021,
436 s,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
Detekce nádorových biomarkerů v molekulárně biologické laboratoři,
1. vyd,
Olomouc,
Univerzita Palackého v Olomouci,
2012,
144 s,
Dedication: MOLONKOL CZ.1.07/2.3.00/09.0089,
ISBN: 978-80-244-3002-7,
Intellectual property
Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer (Šurinová)
- Published Application PCT/EP2013/057111 under WO 2013/152989 (17.10.2013)
Status: Terminated
Postdoctoral mentorship
Stránská Jana Ph.D.
Biomarkers for prognostic and predictive purposes
Doctoral mentorship
Gyurka Kamil Levente
Cell line authentication using PCR High Resolution Melting Analysis
Status:
Ongoing from 2016 to 2016.
Urbanovská Irena
Genetic and epigenetic characterization of patients with glioblastoma
Status:
Ongoing from 2009 to 2009.
Master mentorship
Remešová Eliška
Bisulfite reaction alternatives for cytosine methylation detection
Status:
Ongoing from 2022.
Gabčová Gabriela B.Sc.
Detection of predictive genetic oncomarkers of EGFR signalling pathway using sequencing technologies
Status:
Graduated from 2010 to 2015.
Bachelor mentorship
Gabčová Gabriela B.Sc.
Experimental design for CE mark of V600E BRAF genotyping kit
Status:
Graduated from 2011 to 2013.
Open positions
Project: | Genetic and epigenetic biomarkers of cancer diseases |
---|---|
Supervisors: | Drábek Jiří Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | 1 place in full-time study |
Project: | Genetic and epigenetic biomarkers in cancer |
---|---|
Supervisors: | Drábek Jiří Ph.D., Slavkovský Rastislav Ph.D., Hajdúch Marián M.D., Ph.D. |
Available: | 3 |
Intended for: | Doctoral training |
Summary: | Clonal hematopoiesis of indeterminate potential (CHIP) has recently been described as a common phenomenon associated with aging. It is characterized by the accumulation of somatic mutations in cells of the hematopoietic system. Although CHIP is manifested by the expansion of certain cell clones, this condition is not accompanied by any morphological features of hematological neoplasia. However, it has been shown that the incidence of clonal hematopoiesis correlates with increased overall mortality and the risk of developing malignant transformation of hematopoietic cells as well as cardiovascular disease, such as ischemic stroke. To what extent and by what mechanisms clonal hematopoiesis contributes to disease development remains a question of current research. The main aim of the project will be to pinpoint the principal cells carrying CHIP somatic mutations, and to study their role in development and maintenance of atherosclerotic plaques, especially of those involved in development of stroke. The comparison of the phenotype of CHIP positive and negative cells will be of special interest. The use of cellular models not only include different types of leucocytes but circulatory progenitor endothelial cells as well. The study will involve elderly subjects with the positive presence of CHIP (>65 years). Subject will be characterized based on the presence or absence of ischemic stroke and the presence or absence of carotid stenosis by our clinical collaborators. The presence of somatic variants in 38 selected genes associated with CHIP will be tested in subjects of interest within our research group. The project will use various techiques including FACS, MACS, cell cultures, DNA isolation from small amount of cells, a highly sensitive sequencing method for DNA genotyping allowing detection of variant with less than 1% allelic frequency, DNA/RNA sequencing library preparation, deep massively parallel sequencing of panel of genes using unique molecular barcodes/indices, RNAseq, bioinformatics and data analysis with possibilities of calculations using high performance computing cluster, data management and statistical evaluation. |
Project: | Genetic and epigenetic biomarkers in health and disease |
---|---|
Supervisors: | Slavkovský Rastislav Ph.D., Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D., Drábek Jiří Ph.D., Koudeláková Vladimíra Ph.D. |
Available: | 5 |
Intended for: | Doctoral training |
Project: | Genetic biomarkers |
---|---|
Supervisors: | Drábek Jiří Ph.D. |
Available: | 1 |
Intended for: | Master training |
Project: | Epigenetic biomarkers |
---|---|
Supervisors: | Drábek Jiří Ph.D. |
Available: | 1 |
Intended for: | Master training |